These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5952046)

  • 1. Advantages of universal coding and classification system for drugs. Drug classification activities of the American Medical Association.
    Seitner PG
    Am J Hosp Pharm; 1966 Feb; 23(2):88-92. PubMed ID: 5952046
    [No Abstract]   [Full Text] [Related]  

  • 2. Advantages of a universal coding and classification system for drugs. Implications of classification for medical subject headings.
    McCann A
    Am J Hosp Pharm; 1966 Feb; 23(2):87-8. PubMed ID: 5952045
    [No Abstract]   [Full Text] [Related]  

  • 3. Advantages of a universal coding and classification system for drugs. Classification and coding system of the American Hospital Formulary Service.
    Cleveland CB
    Am J Hosp Pharm; 1966 Feb; 23(2):95-7. PubMed ID: 5907119
    [No Abstract]   [Full Text] [Related]  

  • 4. Advantages of a universal coding and classification system for drugs. Structure of classifications and codes in the De Haen Drug Index Cards.
    Savitz GS
    Am J Hosp Pharm; 1966 Feb; 23(2):92-5. PubMed ID: 5907118
    [No Abstract]   [Full Text] [Related]  

  • 5. New drugs: the AMA and FDA roles.
    Appel JZ
    J Ark Med Soc; 1966 Jul; 63(2):67-9. PubMed ID: 4223555
    [No Abstract]   [Full Text] [Related]  

  • 6. Techniques for selecting, evaluating & compacting the drug literature. American Medical Association.
    Conrad EA
    Am J Hosp Pharm; 1966 Feb; 23(2):60-3. PubMed ID: 5952044
    [No Abstract]   [Full Text] [Related]  

  • 7. Procedure for evaluation of new drugs.
    Weston JK
    J New Drugs; 1965; 5(5):294-6. PubMed ID: 5887954
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug names--a semblance of order.
    Feldman EG
    J Pharm Sci; 1966 Jun; 55(6):i. PubMed ID: 5924136
    [No Abstract]   [Full Text] [Related]  

  • 9. AMA drug evaluations. A praiseworthy venture.
    Robinson RR; Clapp JR
    Arch Intern Med; 1971 Jul; 128(1):147-8. PubMed ID: 5088410
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug standards laboratory enters second decade.
    Reese KM
    J Am Pharm Assoc; 1972 Jan; 12(1):16-20. PubMed ID: 5007258
    [No Abstract]   [Full Text] [Related]  

  • 11. Two new efforts to inform patients about drugs launch a post-PPI era.
    Med World News; 1982 Sep; 23(20):8-9. PubMed ID: 11645760
    [No Abstract]   [Full Text] [Related]  

  • 12. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation.
    Daemmrich A
    Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740
    [No Abstract]   [Full Text] [Related]  

  • 13. ADA joins national coding and provider classification projects.
    J Am Diet Assoc; 1999 Jan; 99(1):18. PubMed ID: 9917725
    [No Abstract]   [Full Text] [Related]  

  • 14. Where AMA stands on the issues.
    J Tenn Med Assoc; 1980 Jan; 73(1):25-6, 29. PubMed ID: 7374137
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines on gifts to physicians from industry: an update.
    American Medical Association. Council on Ethical and Judicial Affairs
    Food Drug Law J; 1992; 47(4):445-58. PubMed ID: 11654909
    [No Abstract]   [Full Text] [Related]  

  • 16. The Medicare squeeze.
    Ortolon K
    Tex Med; 2005 Oct; 101(10):57-9. PubMed ID: 17094518
    [No Abstract]   [Full Text] [Related]  

  • 17. Managed care cost containment involving prescription drugs. American Medical Association, Council on Ethical and Judicial Affairs.
    Food Drug Law J; 1998; 53(1):25-34. PubMed ID: 11795334
    [No Abstract]   [Full Text] [Related]  

  • 18. DRUG PROGRAMS OF THE AMERICAN MEDICAL ASSOCIATION.
    HUSSEY HH
    N C Med J; 1964 Sep; 25():371-4. PubMed ID: 14200012
    [No Abstract]   [Full Text] [Related]  

  • 19. Council announces classification of additional products. Council on Dental Therapeutics.
    J Am Dent Assoc; 1971 Oct; 83(4):775-6. PubMed ID: 5289208
    [No Abstract]   [Full Text] [Related]  

  • 20. Classification and coding considerations for drug data base design.
    Forbes MB
    J Clin Comput; 1983; 12(3):88-100. PubMed ID: 10317426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.